Kouitchenside G

CAS No. 1444411-75-9

Kouitchenside G( ——— )

Catalog No. M38379 CAS No. 1444411-75-9

Kouitchenside G is a natural product that can be isolated from Swertia kouitchensis. Kouitchenside G inhibits α-Glucosidase with an IC50 of 956 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Kouitchenside G
  • Note
    Research use only, not for human use.
  • Brief Description
    Kouitchenside G is a natural product that can be isolated from Swertia kouitchensis. Kouitchenside G inhibits α-Glucosidase with an IC50 of 956 μM.
  • Description
    Kouitchenside G is a natural product that can be isolated from Swertia kouitchensis. Kouitchenside G inhibits α-Glucosidase with an IC50 of 956 μM.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IC50: 956 μM (α-Glucosidase)
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1444411-75-9
  • Formula Weight
    596.53
  • Molecular Formula
    C27H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wan LS, et al. Xanthone glycoside constituents of Swertia kouitchensis with α-glucosidase inhibitory activity. J Nat Prod. 2013 Jul 26;76(7):1248-53.?
molnova catalog
related products
  • 1-Oleoyl-rac-glycero...

    1-O-Oleyl-rac-glycerol also known as monoolein is a surfactant that releases free glycerol and oleic acid upon hydrolysis.

  • (2E,4E)-hexa-2,4-die...

    (2E,4E)-hexa-2,4-dien-1-yl acetate is an intermediate of the sex pheromone of the codling moth.

  • Miglitol

    Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to breakdown complex carbohydrates into glucose.